Loading...
Loading...
Application UK00915919781 · Registered
| Application Number | UK00915919781 |
| Status | Registered |
| Owner | P&G Health Germany GmbH |
| Filed | 2016-10-13 |
| Registered | 2017-02-14 |
| Renewal Due | 2026-10-13 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Yes. ELUMEA is currently a registered UK trademark, with renewal due on 2026-10-13. It is protected under UK intellectual property law and can be enforced against infringing uses.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Pharmaceutical preparations and medicinal preparations for the treatment of deficiencies and diseases of the immune system and the central nervous system of the human body; Dietetic food and substances adopted for medical use for the treatment of deficiencies and diseases of the immune system and the central nervous system of the human body; food supplements for humans and babies for the treatment of deficiencies and diseases of the immune system and the central nervous system; plasters and medicated patches; vitamins and vitamin preparations; mineral food supplements for medical purposes; probiotic bacteria preparations for medical purposes.
'ELUMEA' is a registered trademark on the UK IPO register, owned by P&G Health Germany GmbH. The application (UK00915919781) was filed on 13 October 2016 and registered on 14 February 2017. The registration is set to expire on 13 October 2026.
This mark is recorded under Class 5 (pharmaceuticals & medical preparations).
The trademark is represented by D Young & Co LLP.
UK trademark UK00915919781 for the mark 'ELUMEA' in Class 5 is recorded on the UK IPO register as owned by P&G Health Germany GmbH. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Yes — the UK IPO records UK trademark UK00915919781 for the mark 'ELUMEA' as registered.
UK trademark UK00915919781 for the mark 'ELUMEA' is registered in Class 5 (pharmaceuticals & medical preparations). The filed specification reads: Class 5: Pharmaceutical preparations and medicinal preparations for the treatment of deficiencies and diseases of the immune system and the central nervous system of the human body; Dietetic food and substances adopted for medical use for the treatment of deficiencies and diseases of the immune system and the centra…
UK trademark UK00915919781 for the mark 'ELUMEA' was filed at the UK IPO on 13 October 2016 and registered on 14 February 2017.
UK trademark UK00915919781 for the mark 'ELUMEA' is currently recorded as valid until 13 October 2026, at which point it will need to be renewed with the UK IPO to remain in force.
D Young & Co LLP is listed as the attorney / representative of record for UK trademark UK00915919781 for the mark 'ELUMEA' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.